Comparative effects of systemic administration of levofloxacin and cephalexin on fracture healing in rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study aimed to compare the effects of systemic administration of levofloxacin or cephalexin on fracture healing in rats. Materials and Methods: In this animal study, tibial fractures not requiring fixation were artificially induced in 30 male Wistar albino rats using a 1.1 mm surgical bur. The rats were randomly divided into 6 groups (n=5). Groups 1 and 2 received daily subcutaneous saline injections. Groups 3 and 4 received subcutaneous injections of 25 mg/kg levofloxacin twice daily. Groups 5 and 6 received daily subcutaneous injections of 20 mg/kg cephalexin. The rats in Groups 1, 3, and 5 were sacrificed after 1 week, while the rats in Groups 2, 4, and 6 were sacrificed after 4 weeks. The score of fracture healing was determined through histological assessment of sections from the fracture site according to Perry and colleagues. Data were analyzed by Kruskal–Wallis and Mann–Whitney tests. Results: The mean score of fracture healing at 4 weeks was significantly higher than that at 1 week in the saline, levofloxacin, and cephalexin groups (P<0.001). At 1 week, no significant difference was noted among the three groups of saline, levofloxacin, and cephalexin in the mean score of fracture healing (P=0.360). However, this difference was significant at 4 weeks (P=0.018), and the mean score in the saline group was significantly higher com-pared to that in the levofloxacin group (P=0.015). Conclusion: It is recommended not to prescribe levofloxacin for more than 1 week after surgical management of bone fractures due to its possible adverse effects on fracture healing.
Abstract
Objectives: This study aimed to compare the effects of systemic administration of levofloxacin or cephalexin on fracture healing in rats. Materials and Methods: In this animal study, tibial fractures not requiring fixation were artificially induced in 30 male Wistar albino rats using a 1.1 mm surgical bur. The rats were randomly divided into 6 groups (n=5). Groups 1 and 2 received daily subcutaneous saline injections. Groups 3 and 4 received subcutaneous injections of 25 mg/kg levofloxacin twice daily. Groups 5 and 6 received daily subcutaneous injections of 20 mg/kg cephalexin. The rats in Groups 1, 3, and 5 were sacrificed after 1 week, while the rats in Groups 2, 4, and 6 were sacrificed after 4 weeks. The score of fracture healing was determined through histological assessment of sections from the fracture site according to Perry and colleagues. Data were analyzed by Kruskal–Wallis and Mann–Whitney tests. Results: The mean score of fracture healing at 4 weeks was significantly higher than that at 1 week in the saline, levofloxacin, and cephalexin groups (P<0.001). At 1 week, no significant difference was noted among the three groups of saline, levofloxacin, and cephalexin in the mean score of fracture healing (P=0.360). However, this difference was significant at 4 weeks (P=0.018), and the mean score in the saline group was significantly higher com-pared to that in the levofloxacin group (P=0.015). Conclusion: It is recommended not to prescribe levofloxacin for more than 1 week after surgical management of bone fractures due to its possible adverse effects on fracture healing.
참고문헌 (39)
- Shokier H, "Experimental use of autogenous bone grafts as an alternative method for bone plates in treatment of mandibular fracture", Aust J Basic Appl Sci, 4, pp.1466~1472 (2010)
- Uçan MC, "Influence of caffeic acid phenethyl ester on bone healing in a rat model", J Int Med Res, 41, pp.1648~1654 (2013)[DOI]
- Hausman MR, "Prevention of fracture healing in rats by an inhibitor of angiogenesis", Bone, 29, pp.560~564 (2001)[DOI]
- Keramaris NC, "Fracture vascularity and bone healing : a systematic review of the role of VEGF", Injury, 39(Suppl 2), pp.S45~S57 (2008)[DOI]
- Cook JJ, "Healing in the new millennium : bone stimulators : an overview of where we've been and where we may be heading", Clin Podiatr Med Surg, 32, pp.45~59 (2015)[DOI]
- Mohsen MalekiGorji, "The effect of two phosphodiesterase inhibitors on bone healing in mandibular fractures (animal study in rats)", 대한구강악안면외과학회지, 46(4), pp.258~265 (2020), 대한구강악안면외과학회[DOI]
- Massari L, "Pulsed electromagnetic fields and low intensity pulsed ultrasound in bone tissue", Clin Cases Miner Bone Metab, 6, pp.149~154 (2009)
- Perry AC, "Levofloxacin and trovafloxacin inhibition of experimental fracture-healing", Clin Orthop Relat Res, 414, pp.95~100 (2003)[DOI]
- Maxwell A, "The molecular basis of quinolone action", J Antimicrob Chemother, 30, pp.409~414 (1992)[DOI]
- Rissing JP, "Antimicrobial therapy for chronic osteomyelitis in adults : role of the quinolones", Clin Infect Dis, 25, pp.1327~1333 (1997)[DOI]
- Davis R, "Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy", Drugs, 47, pp.677~700 (1994)[DOI]
- Shahabadi N, "DNA binding studies of antibiotic drug cephalexin using spectroscopic and molecular docking techniques", Nucleosides Nucleotides Nucleic Acids, 38, pp.428~447 (2019)[DOI]
- Papich MG, "Cephalexin susceptibility breakpoint for veterinary isolates : Clinical Laboratory Standards Institute revision", J Vet Diagn Invest, 30, pp.113~120 (2018)[DOI]
- Huddleston PM, "Ciprofloxacin inhibition of experimental fracture healing", J Bone Joint Surg Am, 82, pp.161~173 (2000)[DOI]
- Atalay Y, "Pentoxifylline and electromagnetic field improved bone fracture healing in rats", Drug Des Devel Ther, 9, pp.5195~5201 (2015)[DOI]
- Clark JD, "Special report : the 1996 guide for the care and use of laboratory animals", ILAR J, 38, pp.41~48 (1997)[DOI]
- Krischak GD, "The non-steroidal anti-inflammatory drug diclofenac reduces appearance of osteoblasts in bone defect healing in rats", Arch Orthop Trauma Surg, 127, pp.453~458 (2007)[DOI]
- Andrejs Sitovs, "Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus)", Journal of Veterinary Science, 21(2), pp.0~0 (2020), 대한수의학회[DOI]
- Williams BH, "Therapeutics in ferrets", Vet Clin North Am Exot Anim Pract, 3, pp.131~153 (2000)[DOI]
- Hernandez RK, "Patientrelated risk factors for fracture-healing complications in the United Kingdom General Practice Research Database", Acta Orthop, 83, pp.653~660 (2012)[DOI]
- Bratzler DW, "Clinical practice guidelines for antimicrobial prophylaxis in surgery", Surg Infect(Larchmt), 14, pp.73~156 (2013)[DOI]
- Pountos I, "The effect of antibiotics on bone healing : current evidence", Expert Opin Drug Saf, 10, pp.935~945 (2011)[DOI]
- Kallala R, "In vitro and in vivo effects of antibiotics on bone cell metabolism and fracture healing", Expert Opin Drug Saf, 11, pp.15~32 (2012)[DOI]
- Holtom PD, "Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro", J Orthop Res, 18, pp.721~727 (2000)[DOI]
- Salzmann GM, "Effects of cefuroxime on human osteoblasts in vitro", J Biomed Mater Res A, 82, pp.462~468 (2007)[DOI]
- Edin ML, "Effect of cefazolin and vancomycin on osteoblasts in vitro", Clin Orthop Relat Res, 333, pp.245~251 (1996)
- Brown SA, "Fluoroquinolones in animal health", J Vet Pharmacol Ther, 19, pp.1~14 (1996)[DOI]
- Martinez M, "Pharmacology of the fluoroquinolones : a perspective for the use in domestic animals", Vet J, 172, pp.10~28 (2006)[DOI]
- Förster C, "Quinolone-induced cartilage lesions are not reversible in rats", Arch Toxicol, 70, pp.474~481 (1996)[DOI]
- Gough A, "Quinolone arthropathy in immature rabbits treated with the fluoroquinolone, PD 117596", Exp Toxicol Pathol, 48, pp.225~232 (1996)[DOI]
- Kato M, "Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo", Antimicrob Agents Chemother, 39, pp.1979~1983 (1995)[DOI]
- Linseman DA, "Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin", Fundam Appl Toxicol, 28, pp.59~64 (1995)[DOI]
- Shakibaei M, "Comparative evaluation of ultrastructural changes in articular cartilage of ofloxacin-treated and magnesiumdeficient immature rats", Toxicol Pathol, 24, pp.580~587 (1996)[DOI]
- Egerbacher M, "Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture", Am J Vet Res, 62, pp.704~708 (2001)[DOI]
- Egerbacher M, "Ciprofloxacin causes cytoskeletal changes and detachment of human and rat chondrocytes in vitro", Arch Toxicol, 73, pp.557~563 (2000)[DOI]
- Stahlmann R, "Safety profile of grepafloxacin compared with other fluoroquinolones", J Antimicrob Chemother, 40(Suppl A), pp.83~92 (1997)[DOI]
- Förster C, "Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures", Arch Toxicol, 72, pp.411~419 (1998)[DOI]
- Menschik M, "Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro", Antimicrob Agents Chemother, 41, pp.2562~2565 (1997)[DOI]
- Long F, "Development of the endochondral skeleton", Cold Spring Harb Perspect Biol, 5, pp.a008334~ (2013)[DOI]
